GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Cyp1a1 | decreases expression | EXP | | 6480464 | CTD | Doxorubicin results in decreased expression of CYP1A1 mRNA | PMID:32289291 | Cyp1a1 | increases expression | EXP | | 6480464 | CTD | Doxorubicin results in increased expression of CYP1A1 mRNA; Doxorubicin results in increased expression of CYP1A1 protein | PMID:19796650 | Cyp1a1 | multiple interactions | EXP | | 6480464 | CTD | Doxorubicin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] | PMID:18493746 | Cyp1a1 | decreases expression | ISO | Cyp1a1 (Mus musculus) | 6480464 | CTD | Doxorubicin results in decreased expression of CYP1A1 mRNA | PMID:21040762 | Cyp1a1 | increases expression | ISO | Cyp1a1 (Mus musculus) | 6480464 | CTD | Doxorubicin results in increased expression of CYP1A1 mRNA | PMID:22712078 | Cyp1a1 | multiple interactions | ISO | Cyp1a1 (Mus musculus) | 6480464 | CTD | [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of CYP1A1 mRNA; Lovastatin inhibits the reaction [Doxorubicin results in increased expression of CYP1A1 mRNA] | PMID:21040762 PMID:22712078 | Cyp1a1 | multiple interactions | ISO | CYP1A1 (Homo sapiens) | 6480464 | CTD | Doxorubicin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] | PMID:18493746 | |
Go Back to source page | Continue to Ontology report |